87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known

• William LaFramboise,
• Howard Streicher,
• Patrick Hwu,
• Lisa Butterfield,
• John Kirkwood,
• Jose Conejo-Garcia,
• Sandra Lee,
• Vernon Sondak,
• Walter Storkus,
• Aik Choon Tan,
• Issam El Naqa

Affiliations

William LaFramboise

3 Pathology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

Howard Streicher

Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA

Patrick Hwu

Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Lisa Butterfield

Parker Institute for Cancer Immunotherapy, San Francisco, CA, United States

John Kirkwood

16University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Jose Conejo-Garcia

Department of Immunology, H Lee Moffitt Cancer Center and Research Center, Tampa, Florida, USA

Sandra Lee

3Dana Farber Cancer Institute ECOG-ACRIN, Boston, MA, USA

Vernon Sondak

10H. Lee Moffitt Cancer Center, Tampa, FL, USA

Walter Storkus

University of Pittsburgh, Pittsburgh, PA, USA

Aik Choon Tan

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Issam El Naqa

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA